Ally Bridge Group (NY) LLC

NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$43.4M2026 Q3+ $32.6M options (notional, not included)
Positions18
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.87.9%

Ally Bridge Group (NY) LLC reported 18 positions worth $43.4M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: DFTX (20.0%). Biggest move: exit TRAX ($5.7M).

10 / 18 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 DFTXCallDefinium Therapeutics$15.2M notional20.02%400,000———
▸ 2 ABVXCallAbivax S.A.$12.4M notional16.28%125,000———
▸ 3 EWTXEdgewise Therapeutics$7.5M9.90%185,430——+7.6%
▸ 4 PMNProMIS Neurosciences$6.7M8.85%620,319——-69.5%
▸ 5 NERVMinerva Neurosciences$5.5M7.29%1,655,500———
▸ 6 AMLXAmylyx Pharmaceuticals$5.3M6.96%182,000——-4.5%
▸ 7 STTKShattuck Labs$4.3M5.61%625,190——-14.1%
▸ 8 OBXObsidian Therapeutics$4.2M5.46%302,449———
▸ 9 ALMSCallAlumis$3.0M notional3.89%400,000———
▸ 10 ANTXAN2 Therapeutics$2.8M3.68%526,315——-16.0%

Pro Feature

The remaining 8 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Ally Bridge Group (NY) LLC hold as of Q3 2026?

Ally Bridge Group (NY) LLC reported 18 positions worth $43.4M in its Q3 2026 13F filing. Largest positions: DFTX (20.0%), ABVX (16.3%), EWTX (9.9%), PMN (8.9%) and NERV (7.3%).

What did Ally Bridge Group (NY) LLC buy in Q3 2026?

New positions: AMLX, STTK, OBX, ALMS and CMPX (6 in all). Added to: EWTX.

What did Ally Bridge Group (NY) LLC sell in Q3 2026?

Reduced: ASMB, NERV, CATX, IVA and AVTX (6 in all). Sold out entirely: TRAX, AXSM, WHWK, CLYM and KURA (13 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.